Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615 1621
This examiner grants 49% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18287475 | BIORESORBABLE IMPLANT MATERIALS AND METHODS OF MAKING THE SAME | Non-Final OA | Georgia Tech Research Corporation |
| 18684938 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | Non-Final OA | L'OREAL |
| 18547934 | COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 17996562 | NALOXONE NANOPARTICLE COMPOSITIONS AND METHODS THEREOF | Final Rejection | THE TEXAS A&M UNIVERSITY SYSTEM |
| 18400548 | PREPARATION OF OCCLUSIVE DRESSINGS | Non-Final OA | KPR U.S., LLC |
| 17623394 | STABILIZATION OF RESORCINOL COMPOUNDS IN COSMETIC COMPOSITIONS | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18798718 | OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF USE THEREOF, AND PREPARATION METHODS THEREOF | Non-Final OA | Allgenesis Biotherapeutics Inc. |
| 18380674 | CARRIER FOR PROMOTING FENTON REACTION AND PREPARATION PROCESS AND USES THEREOF | Non-Final OA | National Tsing Hua University |
| 18298348 | Biocampatible and Biodegradable Anionic Hydrogel System | Final Rejection | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS |
| 18678539 | ORAL RIFAMYCIN SV COMPOSITIONS | Non-Final OA | COSMO TECHNOLOGIES LTD. |
| 18665039 | PEPTIDE SLOW-RELEASE FORMULATIONS | Non-Final OA | CAMURUS AB |
| 18245809 | DRY FOAM COMPRISING AGAR-AGAR | Final Rejection | UNIVERSITE PARIS-SACLAY |
| 18444429 | COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF | Non-Final OA | HOLISTA BIOTECH SDN BHD |
| 17283814 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | Final Rejection | ISP INVESTMENTS LLC |
| 18407573 | Lipstick Use And Application | Non-Final OA | Kinky Kitty, LLC |
| 16098145 | IMPROVED DRUG FORMULATIONS | Final Rejection | AustinPx, LLC |
| 18554502 | SYSTEM OF MULTIPLE INTERLOCKING EMBEDMENT | Non-Final OA | CRAFT HEALTH PTE LTD |
| 18230488 | USE OF SYNERGISTIC COMPOSITIONS BASED ON ZOXAMIDE AND CYFLUFENAMID AS FUNGICIDES IN THE AGRONOMIC FIELD | Non-Final OA | Gowan Crop Protection Limited |
| 17226058 | CYCLOBENZAPRINE TREATMENT FOR SEXUAL DYSFUNCTION | Final Rejection | TONIX PHARMA LIMITED |
| 18036664 | COATED MEDICAL PRODUCT | Non-Final OA | Freudenberg Medical Hemoteq GmbH |
| 18138904 | ENCAPSULATION OF PANCREATIC CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS | Non-Final OA | ViaCyte, Inc. |
| 18028164 | INHALED ARGON FOR TREATING A PATIENT SUFFERING FROM CARDIOVASCULAR DISEASE | Non-Final OA | Ecole Nationale Veterinaire d'Alfort |
| 18245615 | COMPOSITIONS COMPRISING A MINERAL SALT FOR ORAL USE | Final Rejection | DIFASS INTERNATIONAL S.P.A. |
| 18006164 | CRYSTALLINE ZIRCONIUM PHOSPHATE FOR USE IN THERAPY, PHARMACEUTICAL COMPOSITION, AND USE OF THE SAME | Final Rejection | CJ Tech Holdings Pte Ltd. |
| 17759688 | GRANULAR PHARMACEUTICAL PRODUCT FOR ORAL ADMINISTRATION FROM A PRE-FILLED STRAW AND METHOD OF MANUFACTURING SUCH PHARMACEUTICAL PRODUCT | Non-Final OA | ALTERNO LABS D.O.O. |
| 17782893 | IMPROVED WOUND CARE DEVICE | Non-Final OA | AMFERIA AB |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy